Spirometer Market Insights, Technology and Forecast Analysis 2021-2028
Spirometer Market |
A Spirometer measures the amount of air that enters and leaves the
lungs while breathing to determine lung capacity. During a spirometer test, the
patient inhales deeply into a tube that is connected to a reader and used to
measure and record the lung's air capacity. Any departure from the expected
spirometer readings suggests a problem with the lungs. Chronic pulmonary
illnesses such cystic fibrosis, pulmonary fibrosis, emphysema, chronic
bronchitis, asthma, bronchiectasis, and others can be diagnosed with a spirometer.
In cases of chronic pulmonary
disorders, a spirometer can also help with breathing exercises to reduce fluid
and mucus buildup in the lungs. Prior to undergoing surgery, including
bariatric surgery, knee replacement surgery, and others, lung function can also
be evaluated with a spirometer.
The Spirometer Market is
anticipated to be driven by rising home healthcare demand, a growth in the
prevalence of chronic respiratory disorders, and technological advances. 90% of
people worldwide breathe dirty air, according to the World Health Organization
(WHO). The lungs are negatively impacted by pollutants and irritants in a
variety of ways. For screening purposes in an occupational setting, the
spirometry apparatus assists in the identification of a number of respiratory
ailments, including obstructive chronic pulmonary disease, emphysema, asthma,
and other breathing problems. In the upcoming years, there will probably be
more demand for spirometers due to the rise in COPD patients throughout the
world.
According to Coherent Market Insights, The global Spirometer Market is estimated to be valued at US$ 958.0 million in 2021 and is expected to exhibit a CAGR of 9.5% over the forecast period (2021-2028).
Companies are creating
spirometers with enhanced design and functionality to help patients and medical
professionals understand the complicated process involved in pulmonary function
testing. The major goal is to create spirometers that produce more while
improving patient comfort without any consequences. In order to avoid potential
bacterial infections, businesses are also implementing novel packaging
practises. These technological advancements simplify and ease the testing
processes for patients.
Spirometry is not frequently used
to diagnose asthma in paediatric patients, particularly in resource-poor
nations where the prevalence of non-communicable illnesses is greater. The
burden of non-communicable illnesses can be decreased by strategies to improve
the use of spirometry measurement. Therefore, it is projected that increased
efforts to provide paediatric care and the usage of contemporary spirometry
equipment that standardize test findings and offer rapid replies would propel
the market's expansion. Patients' preferences for home treatment have risen in
recent years. One of the main drivers of the market's expansion is the concept
of treating patients in the convenience of their own homes. The growing
popularity of home healthcare has led to the creation of tele-spirometers.
Top Companies involved are- Koninklijke
Philips N.V., SCHILLER, Midmark
Corporation, Smiths Medical, Vyaire Medical, Inc., SDI Diagnostics, Nihon
Kohden Corporation, COSMED srl, Fukuda Sangyo Co. Ltd., Medicare Systems, MGC
Diagnostics Corporation, LabTech, Vitalograph, Futuremed, Geratherm Medical AG,
Guangzhou Medsinglong Medical Equipment Co., Ltd, and Welch Allyn
Comments
Post a Comment